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Abstract
Background: Tuberculosis caused by Mycobacterium bovis (M. bovis) is very uncommon in horses worldwide.
Case presentation: In the current study, an eight-year-old male Thoroughbred in good body condition was admitted
to the Equine Clinic at the Onderstepoort Veterinary Academic Hospital in 2005 due to bilateral epistaxis accompanied
by coughing. Routine examinations were conducted to determine the cause of the condition. Endoscopic examination
revealed the major source of the epistaxis as the trachea, whereas thoracic radiography indicated the presence of a
primary pulmonary mass. M. bovis was isolated from a broncho-alveolar lavage (BAL) sample collected. The pulmonary
mass reduced in size three months later following an oral administration of enrofloxacin (7.5 mg/kg PO SID). Genetic
fingerprinting by spoligotyping identified the M. bovis isolate as spoligotype SB0868 strain. This M. bovis strain type was
never described previously in South Africa (SA). This is the first case of M. bovis infection in a horse in SA which has
been fully documented including clinical findings, isolation and genetic characterisation of the causative pathogen.
Conclusions: This report indicates that horses may contract and harbour M. bovis despite their lower susceptibility
compared to other domestic animals. It also suggests that the infection may be more easily contained and eliminated
from the host.
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Background
Mycobacterium bovis is the causative agent of bovine
tuberculosis (BTB) in a variety of mammalian hosts. The
worldwide status of BTB as a zoonosis is of great
concern [1]. Horses are suggested to be more resistant to
mycobacterial infections as compared to other livestock
animals [2] and tuberculosis incidence in horses is
extremely low, especially in countries implementing BTB
control programs [3]. Currently, the most common causes
of mycobacterial infections in horses are members of
the Mycobacterium avium complex (MAC) species [4],
but under conditions of high infection pressure from
co-grazing cattle, M. bovis may cause clinical pulmo-
nary infection in horses [5].
Amongst members of the Mycobacterium tuberculosis
complex (MTBC), M. bovis has been more commonly
isolated from horses than M. tuberculosis [3]. Isolation of
M. bovis was reported from a cheek lesion of a 9-year-old
horse from Nigeria [6]. Acid-fast bacilli were detected on
a splenic aspirate from a 10-year-old mare with weight
loss in Spain. This mare was euthanized and M. bovis
infection confirmed by polymerase chain reaction (PCR)
and culture of tissue samples. In the cited case, a rapid
diagnosis was obtained by use of PCR following ante-
mortem detection of acid-fast bacteria [7]. In another
report, M. bovis was isolated from lymph nodes of a 4-year-
old horse in France that had been in close contact with
infected cattle, supporting that horses may be more easily
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infected under conditions of high M. bovis infection pres-
sure [5]. Most recently, M. bovis infection was confirmed
by PCR of tissue samples collected post mortem from a
2-year-old horse with diarrhea and weight loss associated
with granulomatous enterocolitis [8]. An antibody response
to M. tuberculosis antigens was detected in blood samples
obtained ante-mortem from a 20-year-old horse with signs
of cardiac insufficiency and ventral edema in Switzerland
[9]. M. tuberculosis pulmonary infection was subsequently
confirmed by PCR amplification of DNA extracts from
formalin fixed paraffin embedded tissue samples. Generally
serological diagnosis of tuberculosis is of limited value in
animals and humans and humoral immune responsiveness
to MTBC is indicative of progressive tuberculous lesion
development [10].
In this report, we describe for the first time, the isolation
and molecular characterization of M. bovis in a horse in
South Africa.
Case presentation
An 8-year-old, 563-kg Thoroughbred gelding was admitted
to the Equine Clinic, Onderstepoort Veterinary Academic
Hospital with a primary complaint of bilateral epistaxis,
first noted 6 days prior to admission. The epistaxis had
increased in severity and frequency, and was accompanied
by coughing. The gelding had been purchased for show
jumping 1 month previously and transported approximately
1600 km to a new stable yard. No exercise intolerance was
reported since purchase.
On presentation the gelding was in good body condition,
bright, alert and responsive with good appetite. Body
temperature was mildly elevated (38.6 °C; reference range
(RR) 37.5–38.5), pulse rate was mildly elevated (46 beats
per minute; RR: 28–40) and respiratory rate was normal
(16 breaths per minute; RR: <20/min). Mucous membranes
were pink and moist with no petechiae. Intermittent, mild
epistaxis was evident at both nares. No crackles or wheezes
were detected on thoracic auscultation and no spontaneous
coughing or coughing on rebreathing examination was
recorded. Moderate hypoalbuminemia (22 g/L; RR: 66–83)
was present. Serological testing for Aspergillus antibodies
was negative.
Respiratory endoscopy1 revealed petechiae in the medial
compartment of the left guttural pouch but no blood.
Frank blood was observed in the trachea with hemorrhage
originating from a tertiary bronchiole in the left dorsal
lung lobe. Trans-endoscopic broncho-alveolar lavage was
performed in the region of the hemorrhage and samples
submitted for cytology, bacterial and fungal culture.
Cytology of the BAL fluid was consistent with pulmonary
hemorrhage with chronic inflammation (sero-sanguinous
fluid with 42% neutrophils, 23% lymphocytes, and 35 %
macrophages with phagocytosed red blood cells). Few free
and phagocytosed bacilli were observed. Initial aerobic
and anaerobic bacterial and fungal culture results were
negative. Standing left lateral thoracic radiographs2 revealed
a well-marginated soft tissue mass (12 × 15cm) with a
dorsal gas cap in the caudodorsal lung field. The fluid line
observed in the structure was undulated, indicative of
viscous content. A marked peribronchial infiltration with a
mild alveolar pattern was observed over the ventral lung
field. Thoracic ultrasonography3 only revealed pleural sur-
face irregularity of the left lung. Differential diagnoses
for the imaging findings included a pulmonary abscess,
neoplasia, or fungal granuloma.
Three percutaneous, ultrasound-guided biopsies were
collected from the left caudodorsal lung at the site most
affected by pleural irregularity. Direct ultrasound-guided
biopsy of the pulmonary mass was not possible due to its
depth and ultrasound reverberation artefact. Histopatho-
logical examination of the lung biopsies showed chronic
fibrinous pleurisy of the superficial lung, but was not
diagnostic. The owner declined further diagnostic proce-
dures to sample the pulmonary mass and the gelding was
discharged with treatment for suspected pulmonary bacte-
rial abscess or fungal granuloma with a course of enroflo-
xacin4 (7.5 mg/kg PO q24h for 8 weeks) and Potassium
Iodide(KI5)(10 g PO q24h for 6 months), with paddock
rest.
Three months later, the horse was re-examined and was
found to be in good body condition. The owner reported
that there had been no further epistaxis or coughing. Clin-
ical examination was normal and there was no respiratory
abnormality detected on auscultation. CBC and fibrinogen
results were within reference range. Thoracic radiographs
showed moderate reduction in size of the pulmonary mass
(9 cm diameter) which was of homogeneous soft tissue
opacity, with no gas cap evident. A mild to moderate, focal
broncho-interstitial pattern was present caudodorsal to
the cardiac silhouette, but was markedly improved com-
pared to previous examination. In view of the reduction in
size of the mass, bacterial or fungal granuloma were still
considered the most likely differential diagnoses, with
neoplasia considered unlikely. The horse was discharged
with a further 3-month course of KI. Resumption of
ridden walking exercise was recommended with conti-
nued monitoring for coughing and epistaxis.
A BAL sample from the initial examination had been
subjected to mycobacterial culture according to the
laboratory standard operating procedure at the Tubercu-
losis Laboratory of ARC-Onderstepoort Veterinary Insti-
tute. Briefly, the sample was decontaminated for 10 min
using 4 % NaOH, centrifuged at 3500 rpm for 10 min and
the pellet neutralized with sterile distilled water and
centrifuged as before. The resulting pellet was inoculated
onto Löwenstein-Jensen media slopes, supplemented
with glycerol and pyruvate known to promote growth of
Mycobacterium bovis (M. bovis), and incubated at 37 °C.
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Mycobacterial identification of acid-fast colonies was done
as previously described [11]. In brief, the mycobacterial
isolates were confirmed as members of the Mycobacte-
rium tuberculosis complex (MTBC) by using PCR amplifi-
cation of the MTBC specific 372 bp product and as
M. bovis by amplification of the 206 bp product within the
RD9 region of difference in MTBC organisms. These
results were available only 4 months after initial presenta-
tion and treatment of the horse, and by which time radio-
graphic evaluation had indicated reduction in size of the
pulmonary mass. The zoonotic implications of this condi-
tion were discussed with the owner as soon as mycobac-
terial involvement was confirmed but further testing and
isolation could not be enforced.
Spoligotyping, spacer oligonucleotide typing, which
detects variability in the direct repeat region in the DNA
of MTBC species including M. bovis, and VNTR typing
based on variation in the number of tandem repeat
sequences in the chromosomes of MTBC species, were
used for retrospective molecular characterization of the
isolate as previously described [12, 13]. Spoligotyping
also confirmed the isolates as M. bovis, based on the lack
of spacers 3, 9, 16, 39–43. Additional spacers absent
were 4, 5 and 13. This pattern was consistent with
spoligotype SB0868 reported in the international M. bovis
database (www.mbovis.org). VNTR typing based on a 13
loci VNTR panel was performed as described previously
[13], and revealed a unique VNTR profile (6425346436553)
which has not been detected in South Africa before.
Six years after initial examination the then 15-year-old
gelding was admitted by a new owner for colic and stand-
ing, laparoscope-assisted surgery for left dorsal displace-
ment of the large colon was performed. No link was made
to the previous admission due to the new owner being
unaware of the previous diagnosis. No respiratory tract
abnormalities were reported or detected, however, and the
horse made an uneventful recovery from surgery and was
discharged. The gelding was again re-examined 2 years
later as a routine follow-up in this study. He had been in
full work with no report of epistaxis or coughing. Physical
examination disclosed no abnormalities. Thoracic ultra-
sonography6 revealed mild, bilateral pleural surface irregu-
larity of the ventral lung fields, considered incidental.
CBC and serum amyloid A were within reference range.
The owner declined further diagnostics and respiratory
tract sampling to support bacteriological status or cure.
The present report describes the unusual clinical presen-
tation of epistaxis in a horse with a pulmonary mass and
ante-mortem detection of a M. bovis strain not previously
identified in South Africa. Epistaxis as a presenting clinical
sign has not previously been reported with tuberculosis
in horses. More common causes of epistaxis in horses,
that were excluded in this case, include trauma, exercise
induced pulmonary hemorrhage, ethmoid hematoma,
guttural pouch mycosis and coagulopathy [14]. The case
reported was treated with a 2-month course of fluoro-
quinolone antimicrobial, which was associated with reso-
lution of clinical signs and concurrent reduction in size of
the pulmonary mass. In human medicine, fluoroquino-
lones are classified as second line drugs for the treatment
of tuberculosis [15]. The bactericidal activity of fluoroqui-
nolones against M. tuberculosis is important to provide a
rapid reduction in infective load and to sterilize the infec-
tion [16]. Furthermore, use of moxifloxacin fluoroquino-
lone in a combination treatment regimen with rifampin
and pyrazinamide shortened the time to negative lung
cultures, compared to a standard regimen in a murine
model [17]. Whilst fluoroquinolones are currently regarded
as protected antimicrobials in horses [18], the murine effi-
cacy results may explain the positive clinical response to
empirical therapy in the equine case reported. Definitive
diagnosis of equine tuberculosis generally relies on post-
mortem examination with histopathology, culture and PCR
of tissue samples [9].
Infection with M. bovis in horses appears to occur mostly
by ingestion and the most common site of infection is the
gastro-intestinal tract [3]. This is considered unlikely in the
reported case since the lesion was associated with the lungs,
suggesting the respiratory route as the most probable mode
of transmission. Pulmonary granulomatous infection has
been reported previously in a -year-old Camargue stallion
that had direct contact with infected cattle and shared
potentially contaminated pasture [5]. The previous history
of this horse and disease status of cograzing individuals was
not known.
Genotyping results of the M. bovis isolated revealed a
spoligopattern (SB0868) and VNTR profile not previously
identified in South African wildlife or livestock. The
affected horse had been born and was resident in another
province, with one of the lowest incidences of bovine
tuberculosis in the country, before being relocated after
purchase. Based on the time frame between the dates of
purchase and presentation for epistaxis, it is highly impro-
bable that the horse had contracted the disease while in the
possession of the new owner. Unfortunately, no further
historical details were available which could assist in tracing
back the origin of the M. bovis strain.
M. bovis can be transmitted from horses to humans,
and a rare case of zoonotic transmission of M. bovis
associated with the skin of a horse has been described
[6]. This report emphasized the importance of public
awareness and control of the disease with special atten-
tion to those domesticated animals with close contact to
humans such as horses. Horses, like cats, dogs and sheep,
are considered incidental spill-over hosts and infection is
not sustained within the population concerned [19]. In
the present case, M. bovis was isolated from a respiratory
tract sample, signifying that the horse could have been
Hlokwe et al. BMC Veterinary Research  (2016) 12:179 Page 3 of 5
shedding the organism in respiratory secretions. Before
laboratory confirmation of the diagnosis, which was delayed
due to the prolonged culture time for MTBC, the horse
had multiple contacts with other horses and humans,
raising the possibility of disease transmission. While ante-
mortem diagnosis of M. bovis infection is difficult, it is
recommended that horses presenting with similar lesions
should be kept isolated until laboratory exclusion of myco-
bacterial infection, preferably using a more rapid diagnostic
method such as PCR.
Conclusion
In conclusion, this report describes the unusual presen-
tation of epistaxis in a horse secondary to pulmonary
tuberculosis, and supports that horses may contract and
harbor M. bovis despite their reported lower susceptibi-
lity compared to other domestic animals. The source of
this infection is unknown as the M. bovis strain has not
previously been detected in domestic animals or wildlife in
South Africa. The organism was isolated from a BAL
sample, indicating that the horse could have been shedding
the organism and thereby presenting the risk of forward
transmission at the time. Because of the contagious and
zoonotic nature of the disease, it is of outmost importance
to ensure that measures are taken to prevent transmission
of M. bovis between potentially infected horses and
in-contact persons.
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